Target intelligence / Profile preview

Insulin-like growth factor 1 Ec (IGF-1Ec)

Target
IGF-1Ec
Molecular classification
Growth factor, Peptide, Hormone
01

Overview

Insulin-like growth factor 1 Ec (IGF-1Ec), commonly referred to as Mechano-growth factor (MGF) in muscle tissue, is a splice variant of the IGF-1 gene. It is primarily expressed in response to mechanical load or tissue injury, acting as a local autocrine/paracrine repair factor rather than a systemic hormone. IGF-1Ec contains a unique C-terminal E-peptide sequence that distinguishes it from the systemic IGF-1Ea isoform. Its primary biological role involves the activation and proliferation of satellite cells (muscle stem cells), which is crucial for muscle hypertrophy and the repair of damaged fibers. Beyond skeletal muscle, IGF-1Ec has shown potential neuroprotective effects and roles in cardiac tissue repair following injury. While synthetic versions like PEG-MGF have been investigated for treating muscle-wasting conditions, they are also notable for their history of misuse as performance-enhancing drugs in sports.

Other names
Mechano-growth factorMGFIGF-1 isoform 4IGF-1E peptideIGF-1Ec splice variant
02

Mechanism of action

Stimulates the proliferation of muscle stem cells (satellite cells) and promotes local tissue repair through signaling pathways distinct from systemic IGF-1, often acting in an autocrine/paracrine manner.

03

Biological functions

Muscle regenerationSatellite cell activationNeuroprotectionHypertrophyTissue repairCell proliferation
04

Disease associations

Muscular dystrophySarcopeniaMyocardial infarctionNeurodegenerative diseaseMuscle wasting
05

Safety considerations

Risk of misuse in athletics (doping)Potential oncogenic effects due to cell proliferationLimited clinical safety profile in humans
06

Interacting drugs

PEG-MGF (Pegylated Mechano Growth Factor)

1 more in the full profile.

07

Biomarkers

Muscle IGF-1Ec mRNA expressionSerum MGF levels

Beyond the preview

Go deeper on Insulin-like growth factor 1 Ec (IGF-1Ec).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin-like growth factor 1 Ec (IGF-1Ec).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call